510(k) Report

510(k) · Cleared

Cleared

MedDream

K162011510(k) TraditionalCleared Oct 14, 201685-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Softneta Uab · LLZ System, Image Processing, Radiological

Cleared on Oct 14, 2016 after an 85-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 7 later devices descend from it.

Decided
Oct 14, 2016
Review
85 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
0

7 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2020: 1 descendant cleared2022: 2 descendants cleared2024: 1 descendant cleared2023: 1 descendant cleared2026: 2 descendants cleared201620182020202220242026
  1. This deviceK162011 MedDreamSoftneta Uab · 2016
  2. Descendant · cites it directly · 6 of its ownK200546 ZeeroMED ViewO3 Enterprise Srl · 2020
  3. Descendant · 2 generations on · 2 of its ownK233226 FlexView Diagnostic (v1.1.20)Radical Imaging, LLC · 2024
  4. Descendant · 2 generations on · 1 of its ownK221065 MediLabSigma Scientific Services, LLC · 2022
  5. Descendant · 3 generations on · 0 of its ownK262449 AdvaViewAdvahealth Solutions, LLC · 2026
  6. Descendant · 3 generations on · 0 of its ownK253784 3DICOM MD CloudSingular Health Pty, Ltd. · 2026

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2020: 12022: 22023: 12024: 12026: 2
2020high 2 (2022) · low 0 (2021)2026

Most influential descendants

Showing 5 of 7 · See all
  • K200546ZeeroMED ViewO3 Enterprise Srl · 2020 · cites it directly6descendants
  • K233226FlexView Diagnostic (v1.1.20)Radical Imaging, LLC · 2024 · 2 generations on2descendants
  • K221065MediLabSigma Scientific Services, LLC · 2022 · 2 generations on1descendant
  • K262449AdvaViewAdvahealth Solutions, LLC · 2026 · 3 generations on0descendants
  • K2537843DICOM MD CloudSingular Health Pty, Ltd. · 2026 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K162011MedDreamSoftneta Uab2016—
+1K200546ZeeroMED ViewO3 Enterprise Srl2020—
+2K233226FlexView Diagnostic (v1.1.20)Radical Imaging, LLC2024—
+2K221065MediLabSigma Scientific Services, LLC2022—
+3K262449AdvaViewAdvahealth Solutions, LLC2026—
+3K2537843DICOM MD CloudSingular Health Pty, Ltd.2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
202220
202310
202410
202620
FIG. 1 — Lineage of K162011, 2016–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (7)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K200546ZeeroMED ViewO3 Enterprise Srl20206

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K200546 (O3 Enterprise Srl, 2020) has gone furthest, with 6 descendants of its own.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

MedDream is a software medical imaging system used to receive DICOM images, scheduling information and textual reports, organize and store them in an internal format, and to make that information available across a network via web and customized user interfaces. Software is intended for use as a diagnostic, review, and analysis tool by trained professionals such as radiologists, physicians, clinicians.

Contraindications: The MedDream is not intended for the acquisition of mammographic image data and is meant to be used by qualified medical personnel only who are qualified to create and diagnose medical image data.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K162011: MedDream.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K162011

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026